Bioceltix Ratios and Metrics

Market cap in millions PLN. Fiscal year is January - December.

Millions PLN. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 12, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	495	382	431	372	133	172
Market Cap Growth	-10.86%	-11.42%	16.07%	179.48%	-22.49%	-
Enterprise Value	434	359	394	357	130	-
Last Close Price	89.50	77.60	87.60	90.00	38.80	52.20
PB Ratio	7.33	5.22	11.12	35.51	25.82	28.60
P/TBV Ratio	7.33	5.22	11.12	35.51	25.82	28.60
Debt / Equity Ratio	-	0.00	0.02	0.02	0.06	0.09
Net Debt / Equity Ratio	-0.90	-0.93	-0.85	-0.87	-0.74	-0.92
Net Debt / EBITDA Ratio	3.70	4.70	2.32	0.67	0.45	1.37
Net Debt / FCF Ratio	2.94	4.89	1.84	0.60	0.47	1.37
Inventory Turnover	24.71	-	126.03	-	-	-
Quick Ratio	22.49	32.49	18.66	5.23	1.94	3.41
Current Ratio	22.56	32.51	18.69	5.24	2.68	3.42
Return on Equity (ROE)	-33.35%	-27.06%	-59.03%	-175.28%	-160.02%	-
Return on Assets (ROA)	-19.46%	-16.23%	-34.19%	-85.92%	-70.62%	-
Return on Capital Employed (ROCE)	-25.30%	-20.60%	-37.70%	-132.30%	-165.70%	-70.00%
Earnings Yield	-3.44%	-3.97%	-3.37%	-3.68%	-6.71%	-2.56%
FCF Yield	-4.18%	-3.64%	-4.13%	-4.09%	-6.19%	-2.35%
Buyback Yield / Dilution	-8.77%	-10.18%	-15.76%	-17.48%	-5.54%	-